Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Prosthesis Failure × Olanzapine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Vomiting 5 Nausea 5 Neoplasms 4 Hematologic Neoplasms 4 Anorexia 3 Breast Neoplasms 2 Testicular Neoplasms 1 Solid Tumor Patients Receiving High Emetic Risk Multi-day Chemotherapy 1 Prosthesis Failure 1 Opioid-Related Disorders 1 Nutrition Disorders 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1 Gynecologic Cancer 1 Cachexia 1 Advanced Cancer 1

Interventions

Olanzapine 1 Megestrol Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06500234 2024-07-15

Nutrition Impact on Immunotherapy of Cancer

Qingdao Central Hospital

Phase 3 Recruiting

Neoplasms, Nutrition Disorders, Prosthesis Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡